Nxera Pharma Co., Ltd.
SOLTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $33 | $34 | $36 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $7 | $4 | $7 |
| Inventory | $0 | $9 | $9 | $9 |
| Other Curr. Assets | $0 | $5 | $6 | $6 |
| Total Curr. Assets | $0 | $54 | $53 | $58 |
| Property Plant & Equip (Net) | $0 | $7 | $7 | $7 |
| Goodwill | $0 | $26 | $26 | $26 |
| Intangibles | $0 | $51 | $51 | $52 |
| Long-Term Investments | $0 | $4 | $4 | $5 |
| Tax Assets | $0 | $4 | $0 | $0 |
| Other NC Assets | $0 | $0 | $5 | $4 |
| Total NC Assets | $1 | $91 | $92 | $94 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1 | $145 | $146 | $151 |
| Liabilities | – | – | – | – |
| Payables | $0 | $4 | $4 | $4 |
| Short-Term Debt | $0 | $7 | $7 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $4 | $4 | $5 |
| Total Curr. Liab. | $0 | $15 | $14 | $16 |
| LT Debt | $0 | $58 | $60 | $61 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $1 | $0 | $2 |
| Other NC Liab. | $0 | $5 | $5 | $4 |
| Total NC Liab. | $0 | $64 | $64 | $67 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $4 | $4 | $4 |
| Total Liabilities | $1 | $79 | $79 | $83 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $47 | $47 | $47 |
| Retained Earnings | -$0 | -$9 | -$22 | -$21 |
| AOCI | $0 | $7 | $6 | $7 |
| Other Equity | $0 | $21 | $35 | $35 |
| Total Equity | $0 | $66 | $67 | $69 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1 | $145 | $146 | $151 |
| Net Debt | $0 | $32 | $32 | $32 |